Applying the ABCs of Cardiovascular Disease Prevention to the 2023 AHA/ACC Multisociety Chronic Coronary Disease Guidelines
Authors:
- 22 October 2023
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 137 (2) , 85-91
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Disparities in Cardiac Rehabilitation Among Individuals from Racial and Ethnic Groups and Rural Communities—A Systematic ReviewJournal of Racial and Ethnic Health Disparities, 2018
- Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Cognitive Function in a Randomized Trial of EvolocumabNew England Journal of Medicine, 2017
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Depression Treatment and 1-Year Mortality After Acute Myocardial InfarctionCirculation, 2017
- Statin-associated muscle symptoms—Managing the highly intolerantJournal of Clinical Lipidology, 2017
- Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2016
- Statin-Associated Side EffectsJACC, 2016
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000